Hope & Healing for Healers LLC

  • Cancer (Effective 2012)

  • Glaucoma (Effective 2012)

  • Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome (Effective 2012)

  • Parkinson's Disease (Effective 2012)

  • Multiple Sclerosis (Effective 2012)

  • Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity (Effective 2012)

  • Epilepsy (Effective 2012)

  • Cachexia (Effective 2012)

  • Wasting Syndrome (Effective 2012)

  • Crohn's Disease (Effective 2012)

  • Post-Traumatic Stress Disorder (Effective 2012)

  • Sickle Cell Disease (Effective 2016)*

  • Post Laminectomy Syndrome with Chronic Radiculopathy (Effective 2016)*

  • Severe Psoriasis and Psoriatic Arthritis (Effective 2016)*

  • Amyotrophic Lateral Sclerosis (Effective 2016)*

  • Ulcerative Colitis (Effective 2016)*

  • Complex Regional Pain Syndrome, Type 1 and Type II (Effective 2016)*

  • Cerebral Palsy (Effective 2016)

  • Cystic Fibrosis (Effective 2016)

  • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity (Effective 2016)

  • Terminal Illness Requiring End-Of-Life Care (Effective 2016)

  • Uncontrolled Intractable Seizure Disorder (Effective 2016)

  • Spasticity or Neuropathic Pain Associated with Fibromyalgia (Effective 2018)*

  • Severe Rheumatoid Arthritis (Effective 2018)*

  • Post Herpetic Neuralgia (Effective 2018)*

  • Hydrocephalus with Intractable Headache (Effective 2018)*

  • Intractable Headache Syndromes (Effective 2018)*

  • Neuropathic Facial Pain (Effective 2018)*

  • Muscular Dystrophy (Effective 2018)*

  • Osteogenesis Imperfecta (Effective 2018)*

  • Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders (Effective 2018)*

  • Interstitial Cystitis (Effective 2019)*

  • MALS Syndrome (Median Arcuate Ligament Syndrome) (Effective 2019)*

  • Vulvodynia and Vulvar Burning (Effective 2019)*

  • Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*

  • Tourette Syndrome (Effective 2019)*

  • Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention (Effective 2020)*

  • Ehlers-Danlos Syndrome Associated with Chronic Pain (Effective 2020)*

 

* Conditions were approved by the Regulation Review Committee via the recommendation of the Board of Physicians and Commissioner of Consumer Protection.

For Adults, Debilitating Medical Conditions Include:

A patient may only register for a medical marijuana certificate if he or she is a Connecticut resident being treated for a debilitating medical condition by a Connecticut-licensed physician or advanced practice registered nurse.

Qualification Requirements

From the Connecticut Department of Consumer Protection

  • Cerebral Palsy (Effective 2016)

  • Cystic Fibrosis (Effective 2016)

  • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity (Effective 2016)

  • Severe Epilepsy (Effective 2016)

  • Terminal Illness Requiring End-Of-Life Care (Effective 2016)

  • Uncontrolled Intractable Seizure Disorder (Effective 2016)

  • Muscular Dystrophy (Effective 2018)*

  • Osteogenesis Imperfecta (Effective 2018)*

  • Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*

  • Tourette Syndrome for patients who have failed standard medical treatment (Effective 2019)*

For Patients Under 18, Debilitating Medical Conditions Include:

  • Qualifying patient must be a Connecticut resident.

  • Qualifying patient cannot be an inmate confined in a correctional institution or facility under the supervision of the Connecticut Department of Corrections.

Qualifications for a Registration Certificate:

© 2021 by Fanfare Enterprises